Operating cash flow increased 48.1%
Operating cash flow changed +48.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
-$1.4M→-$740,7774 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →FCUV financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding decreased 90.5%
Shares outstanding changed -90.5% from the comparable as-filed period. The change ranks at the 100th percentile of 5 prior comparable changes.
7,386,705→702,7455 prior comparisons
Operating margin moved 413720 bp higher
Operating margin changed +413720 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-4366.71%→-229.51%3 prior comparisons
Total assets changed across a low base
Total assets changed +1096.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
$1.7M→$20.0M4 prior comparisons
Trade receivables changed across a low base
Trade receivables changed +45662.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
$150→$68,6434 prior comparisons
Working capital increased 70.6%
Working capital changed +70.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$707,739→$1.2M4 prior comparisons
Current assets increased 33.0%
Current assets changed +33.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$1.5M→$2.0M4 prior comparisons
Revenue changed across a low base
Revenue changed +1811.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base. This reverses 3 consecutive comparable moves in the opposite direction.
$35,330→$675,1703 prior comparisons
Research & development decreased 22.5%
Research & development changed -22.5% from the comparable as-filed period.
$467,297→$362,1653 prior comparisons
Operating cash-flow margin moved 393285 bp higher
Operating cash-flow margin changed +393285 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-4042.57%→-109.72%3 prior comparisons
R&D / revenue moved 126902 bp lower
R&D / revenue changed -126902 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
1322.66%→53.64%3 prior comparisons
Working capital / assets moved 3623 bp lower
Working capital / assets changed -3623 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
42.26%→6.03%4 prior comparisons
Inventory / revenue moved 37907 bp lower
Inventory / revenue changed -37907 basis points from the comparable as-filed period.
391.65%→12.58%3 prior comparisons
Inventory decreased 38.6%
Inventory changed -38.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$138,370→$84,9504 prior comparisons
Current ratio increased 31.8%
Current ratio changed +31.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
1.85→2.444 prior comparisons
Receivables / revenue moved 974 bp higher
Receivables / revenue changed +974 basis points from the comparable as-filed period.
0.42%→10.17%3 prior comparisons
Operating income decreased 0.4%
Operating income changed -0.4% from the comparable as-filed period.
-$1.5M→-$1.5M3 prior comparisons
Net income decreased 0.9%
Net income changed -0.9% from the comparable as-filed period.
-$1.5M→-$1.5M3 prior comparisons
Current liabilities increased 0.9%
Current liabilities changed +0.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$829,224→$836,4234 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.